Using hierarchical modeling in genetic association studies with multiple markers: Application to a case-control study of bladder cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 6, 2004, Pages 1013-1021

  Hung, Rayjean J ^a,b   Brennan, Paul ^a   Malaveille, Christian ^a   Porru, Stefano ^c   Donato, Francesco ^c   Boffetta, Paolo ^a,d   Witte, John S ^a,e  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1; GLUTATHIONE TRANSFERASE; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE; SULFOTRANSFERASE;

ARTICLE; BLADDER CANCER; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL MODEL;

ARYLAMINE N-ACETYLTRANSFERASE; BAYES THEOREM; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; GENETIC MARKERS; GENETICS, POPULATION; GENOTYPE; HUMANS; ITALY; MALE; MODELS, GENETIC; OCCUPATIONAL EXPOSURE; PEROXIDASE; POLYCYCLIC HYDROCARBONS, AROMATIC; REGRESSION ANALYSIS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 2942586810     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Greenland S, Rothman KJ. Fundamental of epidemiologic data analysis. In: Rothman KJ, Greenland S, editors. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998. p. 201-29.
2. Greenland S. Methods for epidemiologic analyses of multiple exposures: a review and comparative study of maximum-likelihood, preliminary-testing, and empirical-Bayes regression. Stat Med 1993;12:717-36.
3. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
4. Greenland S, Poole C. Empirical-Bayes and semi-Bayes approaches to occupational and environmental hazard surveillance. Arch Environ Health 1994;49:9-16.
5. Witte JS. Genetic analysis with hierarchical models. Genet Epidemiol 1997;14:1137-42.
6. Greenland S. Principles of multilevel modeling. Int J Epidemiol 2000;29:158-67.
7. Greenland S. Introduction to regression modeling. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998. p. 401-32.
8. Witte JS, Greenland S, Haile RW, Bird CL. Hierarchical regression analysis applied to a study of multiple dietary exposures and breast cancer. Epidemiology 1994;5:612-21.
9. Witte JS, Greenland S. Simulation study of hierarchical regression. Stat Med 1996;15:1161-70.
10. Kim LL, Fijal BA, Witte JS. Hierarchical modeling of the relation between sequence variants and a quantitative trait: addressing multiple comparison and population stratification issues. Genet Epidemiol 2001;21 Suppl 1:S668-73.
11. De Roos AJ, Rothman N, Inskip PD, et al. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers & Prev 2003;12:14-22.
12. Aragaki CC, Greenland S, Probst-Hensch N, Haile RW. Hierarchical modeling of gene-environment interactions: estimating NAT2 genotype-specific dietary effects on adenomatous polyps. Cancer Epidemiol Biomarkers & Prev 1997;6:307-14.
13. Shen M, Hung RJ, Brennan P, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers & Prev 2003;12:1234-40.
14. Hung RJ, Boffetta P, Brennan P, et al. Genetic polymorphisms of MPO, COMT, Mnsod and NQ01, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. In press 2004.
15. Hung RJ, Boffetta P, Brennan P, et al. GSTs, NATs, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004;110:598-604.
16. Conti DV, Witte JS. Hierarchical modeling of linkage disequilibrium: genetic structure and spatial relations. Am J Hum Genet 2003;72:351-63.
17. Witte JS, Greenland S, Kim LL. Software for hierarchical modeling of epidemiologic data. Epidemiology 1998;9:563-6.
18. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-61.
19. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003;2:901-8.
20. Petruska JM, Mosebrook DR, Jakab GJ, Trush MA. Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]-pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 1992;13:1075-81.
21. Mallet WG, Mosebrook DR, Trush MA. Activation of (+-)-trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase. Carcinogenesis 1991;12:521-4.
22. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 1992;98:69-74.
23. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996;271:14412-20.
24. Ross D, Traver RD, Siegel D, Kuehl BL, Misra V, Rauth AM. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer 1996;74:995-6.
25. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem-Biol Interact 2000;129:77-97.
26. Zhu BT, Ezell EL, Liehr JG. Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J Biol Chem 1994;269:292-9.
27. McCord JM. Superoxide dismutase in aging and disease: an overview. Methods Enzymol 2002;349:331-41.
28. Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-10.
29. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996;226:561-5.
30. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA 1996;93:4471-3.
31. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol, Biomarkers & Prev 2000;9:29-42.
32. Kogevinas M, Trichopoulos D. Urinary bladder cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Text book of cancer epidemiology. New York: Oxford University Press, Inc.; 2002. p. 446-66.
33. dos Santos Silva I. Size of a study. In: dos Santos Silva I, editor. Cancer epidemiology: principles and methods. Barcelona: IARC Press; 1999. p. 333-53.
34. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
35. Greenland S, Robins JM. Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology 1991;2:244-51.